» Articles » PMID: 19369195

Large-scale Proteomics Analysis of the Human Kinome

Overview
Date 2009 Apr 17
PMID 19369195
Citations 145
Authors
Affiliations
Soon will be listed here.
Abstract

Members of the human protein kinase superfamily are the major regulatory enzymes involved in the activity control of eukaryotic signal transduction pathways. As protein kinases reside at the nodes of phosphorylation-based signal transmission, comprehensive analysis of their cellular expression and site-specific phosphorylation can provide important insights into the architecture and functionality of signaling networks. However, in global proteome studies, low cellular abundance of protein kinases often results in rather minor peptide species that are occluded by a vast excess of peptides from other cellular proteins. These analytical limitations create a rationale for kinome-wide enrichment of protein kinases prior to mass spectrometry analysis. Here, we employed stable isotope labeling by amino acids in cell culture (SILAC) to compare the binding characteristics of three kinase-selective affinity resins by quantitative mass spectrometry. The evaluated pre-fractionation tools possessed pyrido[2,3-d]pyrimidine-based kinase inhibitors as immobilized capture ligands and retained considerable subsets of the human kinome. Based on these results, an affinity resin displaying the broadly selective kinase ligand VI16832 was employed to quantify the relative expression of more than 170 protein kinases across three different, SILAC-encoded cancer cell lines. These experiments demonstrated the feasibility of comparative kinome profiling in a compact experimental format. Interestingly, we found high levels of cytoplasmic and low levels of receptor tyrosine kinases in MV4-11 leukemia cells compared with the adherent cancer lines HCT116 and MDA-MB-435S. The VI16832 resin was further exploited to pre-fractionate kinases for targeted phosphoproteomics analysis, which revealed about 1200 distinct phosphorylation sites on more than 200 protein kinases. This hitherto largest survey of site-specific phosphorylation across the kinome significantly expands the basis for functional follow-up studies on protein kinase regulation. In conclusion, the straightforward experimental procedures described here enable different implementations of kinase-selective proteomics with considerable potential for future signal transduction and kinase drug target analysis.

Citing Articles

Tumor-Intrinsic Kinome Landscape of Pancreatic Cancer Reveals New Therapeutic Approaches.

Xu Y, Peng X, East M, McCabe I, Stroman G, Jenner M Cancer Discov. 2024; 15(2):346-362.

PMID: 39632628 PMC: 11805639. DOI: 10.1158/2159-8290.CD-23-1480.


Isoform-specific C-terminal phosphorylation drives autoinhibition of Casein kinase 1.

Harold R, Tulsian N, Narasimamurthy R, Yaitanes N, Ayala Hernandez M, Lee H Proc Natl Acad Sci U S A. 2024; 121(41):e2415567121.

PMID: 39356670 PMC: 11474029. DOI: 10.1073/pnas.2415567121.


Isoform-specific C-terminal phosphorylation drives autoinhibition of Casein Kinase 1.

Harold R, Tulsian N, Narasimamurthy R, Yaitanes N, Ayala Hernandez M, Lee H bioRxiv. 2024; .

PMID: 39131317 PMC: 11312495. DOI: 10.1101/2023.04.24.538174.


NUAK: never underestimate a kinase.

Skalka G, Whyte D, Lubawska D, Murphy D Essays Biochem. 2024; 68(3):295-307.

PMID: 38939918 PMC: 11576189. DOI: 10.1042/EBC20240005.


Highlighting the Major Role of Cyclin C in Cyclin-Dependent Kinase 8 Activity through Molecular Dynamics Simulations.

Ziada S, Diharce J, Serillon D, Bonnet P, Aci-Seche S Int J Mol Sci. 2024; 25(10).

PMID: 38791449 PMC: 11121562. DOI: 10.3390/ijms25105411.


References
1.
Barvian M, Boschelli D, Cossrow J, Dobrusin E, Fattaey A, Fritsch A . Pyrido[2,3-d]pyrimidin-7-one inhibitors of cyclin-dependent kinases. J Med Chem. 2000; 43(24):4606-16. DOI: 10.1021/jm000271k. View

2.
Schroeder M, Shabanowitz J, Schwartz J, Hunt D, Coon J . A neutral loss activation method for improved phosphopeptide sequence analysis by quadrupole ion trap mass spectrometry. Anal Chem. 2004; 76(13):3590-8. DOI: 10.1021/ac0497104. View

3.
Macek B, Mann M, Olsen J . Global and site-specific quantitative phosphoproteomics: principles and applications. Annu Rev Pharmacol Toxicol. 2008; 49:199-221. DOI: 10.1146/annurev.pharmtox.011008.145606. View

4.
Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

5.
Krause D, Van Etten R . Tyrosine kinases as targets for cancer therapy. N Engl J Med. 2005; 353(2):172-87. DOI: 10.1056/NEJMra044389. View